Figure 4. Serum sNox2-dp levels during hospitalization according to corticosteroid treatment in the whole cohort (panel A), in patients with hs-cTnT>0.014 µg/L (panel B) and in patients with hs-cTnT ≤ 0.014 0.014 µg/L (panel C). Data are expressed as adjusted marginal means (±SE) of log-transformed sNox2-dp levels (MANOVA analyses).